Originally published In Press as doi:10.1074/jbc.M310665200 on November 10, 2003
J. Biol. Chem., Vol. 279, Issue 5, 3877-3884, January 30, 2004
12-O-Tetradecanoylphorbol-13-acetate May Both Potentiate and Decrease the Generation of Apoptosis by the Antileukemic Agent Arsenic Trioxide in Human Promonocytic Cells
REGULATION BY EXTRACELLULAR SIGNAL-REGULATED PROTEIN KINASES AND GLUTATHIONE*
Carlos Fernández
,
Adrián M. Ramos
,
Patricia Sancho¶,
Donna Amrán,
Elena de Blas, and
Patricio Aller||
From the
Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, 28040 Madrid, Spain
Arsenic trioxide (As2O3) caused apoptosis in U-937 human promonocytic cells. This effect was potentiated by the simultaneous addition of the glutathione (GSH) synthesis inhibitor DL-buthionine-(R,S)-sulfoximine or the protein kinase C activators 12-O-tetradecanoylphorbol-13-acetate (TPA) and bryostatin 1. In addition TPA decreased the intracellular GSH content, caused ERK activation, and potentiated the As2O3-provoked activation of p38 and JNK. The addition of N-acetyl-L-cysteine, the PKC inhibitor GF109203X, and the MEK/ERK inhibitors PD98059 and U0126 attenuated both apoptosis induction and GSH decrease, whereas the p38 inhibitor SB203580 and the JNK inhibitor SP600125 were ineffective. TPA also potentiated ERK activation and GSH depletion when added simultaneously to cadmium chloride (CdCl2) and doxorubicin. However, TPA only enhanced apoptosis in the case of CdCl2, which is a GSH-sensitive agent, whereas it reduced the toxicity of doxorubicin and other DNA-specific drugs. Finally, preincubation for 14-24 h with TPA did not potentiate but, instead, attenuated the As2O3- and CdCl2-provoked apoptosis. The same result was obtained by preincubation with bryostatin 1 and other differentiation inducers. It is concluded that TPA increases the apoptotic action of As2O3, an effect mediated by ERK activation and GSH depletion. However, the increase in apoptosis is only effective in non-differentiated cells.
Received for publication, September 26, 2003
, and in revised form, November 7, 2003.
* This work was supported by Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica, Ministerio de Ciencia y Tecnología Grant SAF2001-1219, Fondo de Investigación Sanitaria, Ministerio de Sanidad y Consumo Grant 01/0946, and Dirección General de Investigación, Comunidad de Madrid, Spain Grant 08.3/0011.3/2001. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Recipient of a predoctoral fellowship from the Ministerio de Ciencia y Tecnología, Spain.
Recipient of a postdoctoral fellowship from the Fundación Carolina, Spain.
¶ Recipient of a predoctoral fellowship from the Ministerio de Educación, Cultura y Deporte, Spain.
|| To whom correspondence should be addressed: Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Ramiro de Maeztu 9, 28040 Madrid, Spain. Tel.: 34-918373112 (ext. 4247); Fax: 34-915360432; E-mail: aller{at}cib.csic.es.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W.-Y. Chen, F.-R. Chang, Z.-Y. Huang, J.-H. Chen, Y.-C. Wu, and C.-C. Wu
Tubocapsenolide A, a Novel Withanolide, Inhibits Proliferation and Induces Apoptosis in MDA-MB-231 Cells by Thiol Oxidation of Heat Shock Proteins
J. Biol. Chem.,
June 20, 2008;
283(25):
17184 - 17193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Monick, L. S. Powers, T. J. Gross, D. M. Flaherty, C. W. Barrett, and G. W. Hunninghake
Active ERK Contributes to Protein Translation by Preventing JNK-Dependent Inhibition of Protein Phosphatase 1
J. Immunol.,
August 1, 2006;
177(3):
1636 - 1645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-Y. Chang and S. Miyamoto
Nuclear Factor-{kappa}B Dimer Exchange Promotes a p21waf1/cip1 Superinduction Response in Human T Leukemic Cells
Mol. Cancer Res.,
February 1, 2006;
4(2):
101 - 112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Ramos, C. Fernandez, D. Amran, P. Sancho, E. de Blas, and P. Aller
Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells
Blood,
May 15, 2005;
105(10):
4013 - 4020.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.